JP2019501123A5 - - Google Patents

Download PDF

Info

Publication number
JP2019501123A5
JP2019501123A5 JP2018525573A JP2018525573A JP2019501123A5 JP 2019501123 A5 JP2019501123 A5 JP 2019501123A5 JP 2018525573 A JP2018525573 A JP 2018525573A JP 2018525573 A JP2018525573 A JP 2018525573A JP 2019501123 A5 JP2019501123 A5 JP 2019501123A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
independently
compound according
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018525573A
Other languages
English (en)
Japanese (ja)
Other versions
JP6873993B2 (ja
JP2019501123A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2016/106597 external-priority patent/WO2017084629A1/en
Publication of JP2019501123A publication Critical patent/JP2019501123A/ja
Publication of JP2019501123A5 publication Critical patent/JP2019501123A5/ja
Application granted granted Critical
Publication of JP6873993B2 publication Critical patent/JP6873993B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018525573A 2015-11-20 2016-11-21 大環状広域抗生物質 Active JP6873993B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CNPCT/CN2015/095165 2015-11-20
CNPCT/CN2015/095165 2015-11-20
CNPCT/CN2016/105043 2016-11-08
CNPCT/CN2016/105043 2016-11-08
PCT/CN2016/106597 WO2017084629A1 (en) 2015-11-20 2016-11-21 Macrocyclic broad spectrum antibiotics

Publications (3)

Publication Number Publication Date
JP2019501123A JP2019501123A (ja) 2019-01-17
JP2019501123A5 true JP2019501123A5 (https=) 2020-01-09
JP6873993B2 JP6873993B2 (ja) 2021-05-19

Family

ID=58231314

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018525573A Active JP6873993B2 (ja) 2015-11-20 2016-11-21 大環状広域抗生物質

Country Status (12)

Country Link
US (1) US11072635B2 (https=)
EP (1) EP3377474B1 (https=)
JP (1) JP6873993B2 (https=)
KR (1) KR20180109858A (https=)
CN (1) CN109219596B (https=)
AU (1) AU2016357926B2 (https=)
BR (1) BR112018010267A2 (https=)
CA (1) CA3005551A1 (https=)
IL (1) IL259429B (https=)
MX (1) MX387476B (https=)
RU (1) RU2761476C2 (https=)
WO (1) WO2017084629A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10501493B2 (en) 2011-05-27 2019-12-10 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
BR112016027232A2 (pt) 2014-05-20 2018-06-26 Genentech Inc antibióticos macrocíclicos de amplo espectro
US11072635B2 (en) 2015-11-20 2021-07-27 Rqx Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
UA126027C2 (uk) * 2017-02-15 2022-08-03 АрКьюЕкс ФАРМАСЬЮТІКЛС, ІНК. Макроциклічні антибіотики широкого спектра
JP2020536072A (ja) * 2017-09-29 2020-12-10 ジェネンテック, インコーポレイテッド ペプチド抗生物質複合体およびその使用方法
ES2961566T3 (es) * 2019-05-28 2024-03-12 Hoffmann La Roche Antibióticos macrocíclicos de amplio espectro

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128280A (en) 1959-10-23 1964-04-07 Searle & Co 1-(alkoxylated/halogenated phenyl)-3-pyridylmethylureas
US5204328A (en) 1990-06-26 1993-04-20 Merck & Co., Inc. Peptides having atrial natriuretic factor activity
EP0862638A1 (en) 1995-11-03 1998-09-09 E.I. Du Pont De Nemours And Company Positive selection vector for bacillus sp.
AP1019A (en) 1996-10-18 2001-10-16 Vertex Pharma Inhibitors of serinre proteases, particularly hepatitis C virus NS3 protease.
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB9902399D0 (en) 1999-02-03 1999-03-24 Smithkline Beecham Plc Compounds
US6660832B1 (en) 1999-08-20 2003-12-09 Isis Pharmaceuticals, Inc. Macrocyclic compounds and preparation methods thereof
US6951840B2 (en) 2001-08-31 2005-10-04 Eli Lilly And Company Lipoglycopeptide antibiotics
DE10226921A1 (de) 2002-06-17 2003-12-24 Bayer Ag Antibakterielle Amid-Makrozyklen
AU2004252174A1 (en) 2003-06-26 2005-01-06 Migenix Inc. Compositions of lipopeptide antibiotic derivatives and methods of use thereof
DE10358824A1 (de) 2003-12-16 2005-07-21 Bayer Healthcare Ag Antibakterielle Makrozyklen mit substituiertem Biphenyl
DE102005014245A1 (de) 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Antibakterielle Amid-Makrozyklen V
DE102005014247A1 (de) 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Antibakterielle Amid-Makrozyklen VI
AU2011223790A1 (en) 2010-03-01 2012-08-30 Myrexis, Inc. Compounds and therapeutic uses thereof
MX2012010381A (es) 2010-03-09 2012-11-23 Merck Canada Inc Lipoglicopeptidos en puente que potencian la actividad de antibacterianos de beta-lactama.
US20130130985A1 (en) 2010-04-01 2013-05-23 Paul Alewood Oxytocin peptide analogues
US9187524B2 (en) 2010-09-15 2015-11-17 The Scripps Research Institute Broad spectrum antibiotic arylomycin analogs
US10501493B2 (en) 2011-05-27 2019-12-10 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
TWI642684B (zh) 2011-05-27 2018-12-01 Rqx製藥股份有限公司 廣效性抗生素
CN103159830B (zh) 2011-12-15 2017-06-20 上海来益生物药物研究开发中心有限责任公司 脂肽类化合物
FR2986154B1 (fr) 2012-01-31 2017-08-04 Pierre Fabre Dermo Cosmetique Nouveau systeme photoprotecteur
KR20140140580A (ko) * 2012-03-14 2014-12-09 더 스크립스 리서치 인스티튜트 광범위 항생제 아릴로마이신 유사체
CN103788176A (zh) 2012-10-31 2014-05-14 上海来益生物药物研究开发中心有限责任公司 一种arylomycin类化合物及其制备方法和应用
EA201590871A1 (ru) * 2012-11-21 2015-11-30 АрКьюЭкс ФАРМАСЪЮТИКЛС, ИНК. Макроциклические антибиотики широкого спектра действия
BR112016027232A2 (pt) 2014-05-20 2018-06-26 Genentech Inc antibióticos macrocíclicos de amplo espectro
ITUB20154591A1 (it) 2015-10-12 2017-04-12 Crestoptics S R L Apparato di microscopia confocale e relativo procedimento di acquisizione ed elaborazione di immagini
US11072635B2 (en) 2015-11-20 2021-07-27 Rqx Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
TWI725075B (zh) 2015-11-20 2021-04-21 美商Rqx製藥公司 巨環廣效抗生素
UA126027C2 (uk) 2017-02-15 2022-08-03 АрКьюЕкс ФАРМАСЬЮТІКЛС, ІНК. Макроциклічні антибіотики широкого спектра
CN117777229A (zh) 2017-03-27 2024-03-29 豪夫迈·罗氏有限公司 用于制备阿龙霉素环类似物的方法
JP2020536072A (ja) 2017-09-29 2020-12-10 ジェネンテック, インコーポレイテッド ペプチド抗生物質複合体およびその使用方法
ES2961566T3 (es) 2019-05-28 2024-03-12 Hoffmann La Roche Antibióticos macrocíclicos de amplio espectro

Similar Documents

Publication Publication Date Title
JP2019501123A5 (https=)
JP2019502659A5 (https=)
JP2017517567A5 (https=)
RU2018122505A (ru) Макроциклические антибиотики широкого спектра действия
RU2018122498A (ru) Макроциклические антибиотики широкого спектра действия
JP2016528257A5 (https=)
RU2016107436A (ru) Линейные пептидные антибиотики
JP2013510885A5 (https=)
JP2016501864A5 (https=)
JP2021522262A5 (https=)
JP2021514384A5 (https=)
JP2018533593A5 (https=)
JP2020510044A5 (https=)
JP2018536635A5 (https=)
JP2017528467A5 (https=)
JP2009535358A5 (https=)
JP2019507768A5 (https=)
IL273180B2 (en) Heteroaryl-modified beta-hydroxyethylamines for use in the treatment of hyperglycemia
JP2013510884A5 (https=)
JP2023036007A5 (https=)
JP2021528449A5 (https=)
JP2011530534A5 (https=)
JP2021501756A5 (https=)
JP2010520276A5 (https=)
JP2021522167A5 (https=)